The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Hepatic stellate cells (HSCs) known as “master producers” and macrophages as “master regulators”, are the key cell types that strongly contribute to the progression of liver fibrosis. Since Notch signaling regulates multiple cellular processes, we aimed to study the role of Notch signaling in HSCs differentiation and macrophages polarization and to evaluate its implication in liver fibrogenesis. Notch pathway components were found to be significantly upregulated in TGFβ-activated HSCs, inflammatory M1 macrophages and in mouse and human fibrotic livers. Interestingly, inhibition of Notch using a selective γ-secretase inhibitor, Avagacestat, significantly inhibited TGFβ-induced HSC activation and contractility and suppressed M1 macrophages. Additionally, Avagacestat inhibited M1 driven-fibroblasts activation and fibroblasts-driven M1 polarization (nitric oxide release) in fibroblasts and macrophages co-culture and conditioned medium studies. In vivo , post-disease treatment with Avagacestat significantly attenuated fibrogenesis in CCl 4 -induced liver fibrosis mouse model. These effects were attributed to the reduction in HSCs activation and inhibition of inflammatory M1 macrophages and upregulation of suppressive M2 macrophages. These findings suggest that Notch signaling plays a crucial role in HSC activation and M1/M2 polarization of macrophages in liver fibrosis. These results provide new insights for the development of novel therapies against liver fibrosis through modulation of Notch signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bansal et al. (5) showed that components of the Notch signaling pathway -key mediators of cell-cell communication- are upregulated in HSCs, the principal effectors of fibrogenesis, as well as in pro-fibrotic macrophages in both murine and human livers.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Avagacestat also promoted deactivation of human LX2 cells, an established HSC cell line.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Pharmacological inhibition of Notch signaling using avagacestat, a selective γ-secretase inhibitor, attenuated fibrosis and increased the abundance of pro-resolutive macrophages.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
In the citing paper
“Notch signaling has been identified as an important driver of HSC activation in fibrosis in general (114, 153).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“Additionally, hepatic immunological environment determines the functional plasticity of macrophages varied from classical inflammatory M1 macrophages to alternatively differentiated restorative M2 macrophages 12,29 .”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 3×
“response is predominantly mediated by classically-activated (M1-differentiated) macrophages (activated by Th1 cytokines e.g. IFN-γ , LPS, TNF-α or IL-12) 10–12 .”
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 4×
“Interaction between Notch receptor-and Notch ligand-expressing cells leads to the activation of Notch signaling cascade resulting in the cleavage of ligand-activated Notch receptor by γ -secretase complex 21 .”
InfluentialHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Owing to liver fibrogenesis, quiescent HSCs become activated to a contractile myofibroblast-like matrix-secreting phenotype and secrete fibrillar colla-gens resulting in deposition of fibrotic matrix and scar-tissue formation 6 .”
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Hepatic stellate cells (HSCs) are considered as the major producers of fibrotic ECM during liver fibrosis, but activation of macrophages is also an essential step in the initiation of fibrogenesis and they are signified as positive modulators of fibrosis 25–27 .”
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Cited by
Items 101–107 of 107
Mašek, J., Filipovic, I., Hul, N. V., Belicová, L., Jiroušková, M., Oliveira, D. V., Frontino, A. M., Hankeová, S., He, J., Turetti, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.24.513578
“To determine whether Jag1 Ndr/Ndr lymphocytes affect fibrotic response to BDL, we analyzed periportal expression of cytokeratin 19 (CK19, a marker of cholangiocytes), alpha smooth muscle actin (aSMA, myofibroblast and HSC marker), and collagen1 (an acute fibrotic marker expressed by HSCs (Iwaisako et al , 2014)).”
BackgroundInfluentialThe role of reck in the pathogenesis of nonalcoholic steatohepatitis
Dashek, R. J. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94274
Bronzato, T. C. P., Valente, L. C., Varicoda, A. S., Belin, M. A. F., Grandini, N. A., Vieira, T. A., Cruzeiro, J., Corrêa, C. R., Barbisan, L. F., & Romualdo, G. R. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf092
朱, 芳. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.45459
Fibroblastic heterogeneity and metastatic spread in breast cancers
Pelon, F. (2018) · theses.fr (ABES) · doi:10.70675/829dfe15z9dbfz4622za60cz77fac9fc8a96
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis
Sharmila, M., Harini, K. S., & Ezhilarasan, D. (2026) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2026.04.006
Biliary atresia-related liver fibrosis
Zhou, T., Wang, F., Sun, P., & Kong, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1905495
“…indirectly promote fibrosis: its activation positively correlates with inflammatory cell (macrophage, lymphocyte) infiltration in BA liver tissues (Bansal et al., 2015); it drives M1 macrophage polarization and pro-inflammatory cytokine (TNF-α , IL-6, IL-1 β ) secretion, which further activates…”
Metadata
- Authors
- Bansal, R., van Baarlen, J., Storm, G., & Prakash, J.
- Affiliations
- University of Twente (NL)
- Utrecht University (NL)
- Corresponding author
- Bansal, Ruchi
- Prakash, Jai
- Venue
- Scientific Reports
- Published
- 2015-12-14
- Volume
- 5
- Issue
- 1
- Pages
- 18272-18272
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4677309
- OpenAlex
- W2375249898
- Cited by
- 107
- References
- 42
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 12 · 2022: 7 · 2021: 12 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 8 · 2016: 6
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- University of Twente Research Information (submittedVersion, cc-by)
- Funders
- University of Twente
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- Notch signaling, hepatic stellate cells, liver fibrosis, macrophage polarization, M1/M2 macrophages, gamma-secretase inhibitors, TGF-beta, hepatic stellate cell activation, CCl4-induced fibrosis, fibroblast activation, nitric oxide
- MeSH terms
- Animals, Cell Communication, Cell Differentiation, Cell Line, Disease Models, Animal, Fibroblasts, Humans, Liver Cirrhosis, Macrophage Activation, Macrophages, Oxadiazoles, Sulfonamides, Signal Transduction, Transforming Growth Factor beta, 3T3 Cells, Mice, Receptors, Notch, Hepatic Stellate Cells, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.